Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.750
0.00 (0.00%)
At close: May 30, 2025, 4:00 PM
1.770
+0.020 (1.14%)
After-hours: May 30, 2025, 7:49 PM EDT
Autolus Therapeutics Stock Forecast
AUTL's stock price has decreased by -56.47% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Autolus Therapeutics stock ranges from a low of $6.00 to a high of $13. The average analyst price target of $9.32 forecasts a 432.57% increase in the stock price over the next year.
Price Target: $9.32 (+432.57%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 10, 2025.
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +471.43% | Apr 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +471.43% | Apr 1, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +242.86% | Mar 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +471.43% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +471.43% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
43.47M
from 10.12M
Increased by 329.53%
Revenue Next Year
126.81M
from 43.47M
Increased by 191.73%
EPS This Year
-0.92
from -0.86
EPS Next Year
-0.80
from -0.92
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 65.1M | 224.9M | 512.2M | ||
| Avg | 43.5M | 126.8M | 268.5M | ||
| Low | 18.0M | 89.7M | 110.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 543.3% | 417.3% | 303.9% | ||
| Avg | 329.5% | 191.7% | 111.8% | ||
| Low | 77.6% | 106.3% | -12.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.75 | -0.50 | -0.18 | ||
| Avg | -0.92 | -0.80 | -0.57 | ||
| Low | -1.23 | -1.09 | -1.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.